|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1134 NOK | +1.80% |
|
-5.18% | +29.16% |
Business description: SoftOx Solutions

Number of employees: 2
Sales by Activity: SoftOx Solutions
| Fiscal Period: December | 2021 (NOK) | 2022 (NOK) | 2023 (NOK) | 2024 (NOK) | 2025 (NOK) |
|---|---|---|---|---|---|
Pharmaceuticals | 7.9M | 7.11M | 6.98M | 7.91M | 15.58M |
Geographical breakdown of sales: SoftOx Solutions
| Fiscal Period: December | 2021 (NOK) | 2022 (NOK) | 2023 (NOK) | 2024 (NOK) | 2025 (NOK) |
|---|---|---|---|---|---|
Norway | 7.9M | 7.11M | 6.98M | 7.91M | 15.58M |
Executive Committee: SoftOx Solutions
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 31/08/2024 | |
Ingrid Juven
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 31/12/2025 |
Composition of the Board of Directors: SoftOx Solutions
| Director | Title | Age | Since |
|---|---|---|---|
Ulrik Spork
CHM | Chairman | - | - |
Tore Duvold
BRD | Director/Board Member | 58 | 26/06/2025 |
Adrian Bignami
BRD | Director/Board Member | - | - |
| Director/Board Member | 51 | - |
Company details: SoftOx Solutions

Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.80% | -5.18% | +40.69% | -98.55% | 30M | ||
| -2.86% | -0.26% | +51.45% | +110.98% | 56.42B | ||
| -0.34% | +3.51% | +45.55% | +40.16% | 44.54B | ||
| +0.29% | +6.20% | -14.80% | -19.65% | 22.9B | ||
| -0.40% | +3.49% | -1.29% | +387.06% | 21.21B | ||
| -1.16% | +1.78% | +10.43% | -34.63% | 16.4B | ||
| -1.54% | -1.06% | +7.63% | -39.28% | 15.4B | ||
| -0.24% | +2.44% | +27.43% | +177.49% | 13.35B | ||
| -1.19% | +9.74% | +20.81% | - | 12.36B | ||
| +0.32% | +2.81% | +96.37% | +213.49% | 11.15B | ||
| Average | -0.25% | +0.95% | +28.43% | +81.90% | 21.38B | |
| Weighted average by Cap. | -0.93% | +2.25% | +30.66% | +96.25% |
- Stock Market
- Stocks
- SOFTX Stock
- Company SoftOx Solutions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















